IOVANCE BIOTHERAPEUTICS INC (IOVA)

Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024

Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024

SAN CARLOS, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating,...

Iovance Biotherapeutics to Present at Upcoming Conferences

Iovance Biotherapeutics to Present at Upcoming Conferences

SAN CARLOS, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating,...

Where Will Iovance Biotherapeutics Stock Be in 5 Years?

Is this rising healthcare stock a good buy right now?

The Top 3 Biotech Stocks to Buy in April 2024

Learn about the top three biotech stocks to take advantage of these companies' promising futures and pharmaceutical advances.

3 Millionaire-Maker Biotech Stocks

The risk at these companies is above average, and they're sure to remain volatile. This volatility, however, includes explosively bullish potential.

Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting

Oral Presentation of Updated Results of IOV-COM-202 Cohort 1A of Lifileucel plus Pembrolizumab in Advanced Frontline Melanoma

Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting

Oral Presentation of Updated Results of IOV-COM-202 Cohort 1A of Lifileucel plus Pembrolizumab in Advanced Frontline Melanoma...

These Biotech Stocks Could Soar 120% and 295%, According to Wall Street

Catalysts lie ahead for both of these companies.

These Biotech Stocks Could Soar 120% and 295%, According to Wall Street

Catalysts lie ahead for both of these companies.

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company...

Is Iovance Biotherapeutics Stock a Buy Now?

Let's find out if this biotech can keep up its recent momentum.

Iovance Biotherapeutics Enters Oversold Territory (IOVA)

First Week of May 31st Options Trading For Iovance Biotherapeutics (IOVA)

Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics

These companies are in the early days of their growth stories.

May 10th Options Now Available For Iovance Biotherapeutics (IOVA)

2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street

Find out why investment banks up and down Wall Street have big expectations for these stocks.

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (

7 Biotech Stocks Ready to Ride the Sector’s Resurgence

With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas.

Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead

This company's growth story is about to get moving with gusto.

1 Wall Street Analyst Thinks Iovance Biotherapeutics Stock Is Going to $32. Is It a Buy Around $17?

Its revenue is set to grow, and one of its trials is no longer paused.

Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst

With its first approval in hand, attention is now on the top line.

Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer

Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer

SAN CARLOS, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on...

Could Iovance Biotherapeutics Stock Help You Become a Millionaire?

Does Iovance Biotherapeutics stock possess enough upside to generate life-changing returns for your portfolio?

Iovance Biotherapeutics to Present at Upcoming Conferences

Iovance Biotherapeutics to Present at Upcoming Conferences

SAN CARLOS, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating,...

Why Iovance Biotherapeutics Stock Got Trounced on Thursday

A robust rally ended abruptly with the publication of the company's latest fundamentals.

Iovance Therapeutics Stock Has Skyrocketed Over 100% so Far This Year. Is It Still a Buy?

More gains might be on the way for this high-flying biotech stock.